The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Parasomnias: An Updated Review
Open accessAbstract
Parasomnias are abnormal behaviors emanating from or associated with sleep. Sleepwalking and related disorders result from an incomplete dissociation of wakefulness from nonrapid eye movement (NREM) sleep. Conditions that provoke repeated cortical arousals, or promote sleep inertia lead to NREM parasomnias by impairing normal arousal mechanisms. Changes in the cyclic alternating pattern, a biomarker of arousal instability in NREM sleep, are noted in sleepwalking disorders. Sleep-related eating disorder (SRED) is characterized by a disruption of the nocturnal fast with episodes of feeding after an arousal from sleep. SRED is often associated with the use of sedative-hypnotic medications; in particular, the widely prescribed benzodiazepine receptor agonists. Recently, compelling evidence suggests that nocturnal eating may in some cases be a nonmotor manifestation of Restless Legs Syndrome (RLS). rapid eye movement (REM) Sleep Behavior Disorder (RBD) is characterized by a loss of REM paralysis leading to potentially injurious dream enactment. The loss of atonia in RBD often predates the development of Parkinson's disease and other disorders of synuclein pathology. Parasomnia behaviors are related to an activation (in NREM parasomnias) or a disinhibition (in RBD) of central pattern generators (CPGs). Initial management should focus on decreasing the potential for sleep-related injury followed by treating comorbid sleep disorders. Clonazepam and melatonin appear to be effective therapies in RBD, whereas paroxetine has been reported effective in some cases of sleep terrors. At this point, pharmacotherapy for other parasomnias is less certain, and further investigations are necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tricyclic antidepressants (such as imipramine, amitriptyline), selective serotonin reuptake inhibitors (such as paroxetine, fluoxetine), mirtazapine, and ramelteon have also been used for the treatment of sleep terrors with varying success [25, 57, 65, 83-88].”
From Sleep Terrors: An Updated Review (2020) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anticipatory awakening, performed approximately half an hour before the child is most likely to experience a sleep terror episode, is often effective for the treatment of frequently occurring sleep terrors [9, 22, 42, 57, 65, 76].”
From Sleep Terrors: An Updated Review (2020) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Prolonged episodes usually occur in the setting of poly-neuropharmacy, particularly sedative hypnotics [65].”
From Sleep Terrors: An Updated Review (2020) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–258 of 258
Effect of Genetically Caused Excess of Brain Gamma-Hydroxybutyric Acid and GABA on Sleep
Arnulf, I., Konofal, É., Gibson, K. M., Rabier, D., Beauvais, P., Derenne, J., & Philippe, A. (2005) · SLEEP · doi:10.1093/sleep/28.4.418 · Cited by 48
Olanzapine-Induced Somnambulism
Kolivakis, T., Margolese, H. C., Beauclair, L., & Chouinard, G. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1158 · Cited by 48
Somnambulism Due to Probable Interaction of Valproic Acid and Zolpidem
Sattar, S. P., Ramaswamy, S., Bhatia, S. C., & Petty, F. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c500 · Cited by 48
Severe hypermotility during sleep in treatment of cataplexy with clomipramine.
Bental, E., Lavie, P., & Sharf, B. (1979) · PubMed · Cited by 48
Sleepwalking in Psychiatric Patients: Comparison of Childhood and Adult Onset
Lam, S.-P., Fong, S. Y. Y., Yu, M. W. M., Li, S. X., & Wing, Y. K. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902817703 · Cited by 47
Bupropion-induced somnambulism
KHAZAAL, Y., KRENZ, S., & ZULLINO, D. F. (2003) · Addiction Biology · doi:10.1080/13556210310001602284 · Cited by 46 · cited 1×
“Implicated agents have included antidepressants amitriptyline [28], bupropion [29, 30], paroxetine [31], and mirtazapine [32], the mood stabilizer, lithium [33, 34], the antipsychotics quetiapine [35] and olanzapine [36–38], the antihypertensive agent metoprolol [39], the anti-seizure agent topiramate [40], and the an…”
BackgroundPolysomnographic characteristics of healthy elderly subjects with somnambulism-like behaviors
Tachibana, N., Sugita, Y., Terashima, K., Teshima, Y., Shimizu, T., & Hishikawa, Y. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90065-t · Cited by 45
Paradox lost: midnight in the battleground of sleep and dreams
Reading, D. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.096131 · Cited by 44
Mahowald, M. W., Schenck, C. H., & Bornemann, M. A. C. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0014-3 · Cited by 44
Fluoxetine for Isolated Sleep Paralysis
Koran, L. M., & Raghavan, S. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71913-1 · Cited by 43
Zolpidem, somnambulism, and nocturnal eating
Sansone, R. A., & Sansone, L. A. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.07.005 · Cited by 43
Secondary ‘‘incidental’’ REM sleep behavior disorder: Do we ever think of it?
Manni, R., Ratti, P., & Terzaghi, M. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.10.011 · Cited by 43
Sleepwalking Associated with Hyperthyroidism
Ajlouni, K. M., Ahmad, A. T., Al-Zahiri, M. M., Ammari, F. L., Jarrah, N. S., Abujbara, M. A., Ajlouni, H. K., & Daradkeh, T. K. (2005) · Endocrine Practice · doi:10.4158/ep.11.1.5 · Cited by 42
Zolpidem-induced sleep-related eating disorder
Yun, C., & Ji, K. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.026 · Cited by 41
Increased prevalence of nocturnal smoking in restless legs syndrome (RLS)
Provini, F., Antelmi, E., Vignatelli, L., Zaniboni, A., Naldi, G., Buonaura, G. C., Vetrugno, R., Plazzi, G., Pizza, F., & Montagna, P. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.05.016 · Cited by 41
Somnambulistic-like behaviour in patients attending a lithium clinic
Landry, P., Warnes, H., & Montplaisil, J. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199905002-00004 · Cited by 40
Isolated Cataplexy and REM Sleep Behavior Disorder After Pontine Stroke
Reynolds, T. Q., & Roy, A. (2011) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.28111 · Cited by 40
Hypersynchronous Slow Delta, Cyclic Alternating Pattern and Sleepwalking
(2006) · Sleep · doi:10.1093/sleep/29.1.14 · Cited by 36
On the Reported Association of Psychopathology with Sleep Terrors in Adults
Schenck, C. H., & Mahowald, M. W. (2000) · SLEEP · doi:10.1093/sleep/23.4.1 · Cited by 36
Zolpidem induced nocturnal sleep‐related eating disorder (NSRED) in a male patient
Dang, A., Garg, G., & Rataboli, P. V. (2008) · International Journal of Eating Disorders · doi:10.1002/eat.20620 · Cited by 35
Diazepam in intractable sleepwalking: a pilot study.
Reid, W. H., Haffke, E. A., & Chu, C.-C. (1984) · PubMed · Cited by 33
Kompanje, E. J. O. (2008) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00672.x · Cited by 32
Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder
Miyamoto, M., Miyamoto, T., Iwanami, M., Muramatsu, S., Asari, S., Nakano, I., & Hirata, K. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.03.024 · Cited by 31
Ferini‐Strambi, L. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.10.010 · Cited by 31
Somnambulistic-like behaviour in patients attending a lithium clinic
Landry, P., Warnes, H., Nielsen, T., et al. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199905030-00004 · Cited by 31
Impaired decision-making in idiopathic REM sleep behavior disorder
Sasai, T., Miyamoto, T., Miyamoto, M., Iwanami, M., Abe, T., Matsuura, M., & Inoue, Y. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2011.09.012 · Cited by 30
Sexual behavior in sleep, sleepwalking and possible REM behavior disorder: a case report.
Alves, R., Alóe, F., Tavares, S., Vidrio, S., Yáñez, L., Aguilar‐Roblero, R. A., Rosenthal, L. H. S., Villalobos, L. P., Fernández-Cancino, F., Drucker-Colı́n, R., et al. (1999) · PubMed · Cited by 29
Somnambulism, Bed-Time Medication and Over-Eating
Nadel, C. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.139.1.79a · Cited by 29
REM sleep behavior disorder in a patient with frontotemporal dementia
Coco, D. L., Cupidi, C., Mattaliano, A., Baiamonte, V., Realmuto, S., & Cannizzaro, E. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0702-5 · Cited by 27
New Onset Somnambulism Associated With Different Dosage of Mirtazapine: A Case Report
Yeh, Y.-W., Chen, C.-H., Feng, H.-M., Wang, S.-C., Kuo, S.-C., & Chen, C.-K. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318187bafc · Cited by 27
Sleep-Related Eating Disorder and Zolpidem
Wing, Y. K., Lam, S. P., Li, S. X., Zhang, J., & Yu, M. W. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09l05623gry · Cited by 27
Somnambulism Induced by Quetiapine: Two Case Reports and a Review of the Literature
Hafeez, Z. H., & Kalinowski, C. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900015698 · Cited by 27
Schenck, C. H., & Mahowald, M. W. (2000) · SLEEP · doi:10.1093/sleep/23.5.1 · Cited by 26
Sleep paralysis in adolescents: The ‘a dead body climbed on top of me’ phenomenon in Mexico
Jiménez‐Genchi, A., Ávila-Rodríguez, V. M., Sánchez‐Rojas, F., Terrez, B. E. V., & Nenclares‐Portocarrero, A. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01984.x · Cited by 25
Amitriptyline and Somnambulism
Ferrándiz-Santos, J. A., & Mataix-Sanjuan, A. L. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.10073 · Cited by 24
Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder
Chiu, Y.-H., Chen, C.-H., & Shen, W. W. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.10.006 · Cited by 22
Amnestic syndrome induced by zopiclone
Fava, G. A. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050149 · Cited by 22
Bupropion-Induced Sleepwalking
Oulis, P., Kokras, N., Papadimitriou, G. N., & Masdrakis, V. G. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c9c8a2 · Cited by 22
Late-Life Somnambulism After Therapy With Metoprolol
Hensel, J., & Pillmann, F. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318157425a · Cited by 22
A Case of Zaleplon-Induced Amnestic Sleep-Related Eating Disorder
Molina, S. M., & Joshi, K. G. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09l05364bro · Cited by 22
The REM sleep behavior disorder odyssey
Mahowald, M. W., & Schenck, C. H. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.02.002 · Cited by 20
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers
Bell, C., Wilson, S. J., Rich, A. S., Bailey, J., & Nutt, D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1314-9 · Cited by 19
Increased frequency of self-reported parasomnias in patients suffering from vitiligo.
Mouzas, O. D., Angelopoulos, N. V., Papaliagka, M., & Tsogas, P. (2008) · PubMed · doi:10.1684/ejd.2008.0355 · Cited by 19
AGITATED SLEEPWALKING WITH FLUOROQUINOLONE THERAPY
von Vigier, R. O., Vella, S., & Bianchetti, M. G. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199905000-00024 · Cited by 16
Serotoninergic agents in the treatment of isolated sleep paralysis
Snyder, S., & Hams, G. E. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1202 · Cited by 16
Topiramate induced somnabulism and automatic behaviour.
Varkey, B. M., & Varkey, L. M. (2003) · PubMed · Cited by 15
Mahowald, M. W., Bornemann, M. A. C., & Schenck, C. H. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.11.007 · Cited by 15
Isolated sleep paralysis after rapid time-zone change ('jet-lag') syndrome.
Snyder, S. M. (1984) · PubMed · Cited by 15
Bušek, P., Vaňková, J., Opavsky, J., Salinger, J., Stepanova, I. I., & Nevšímalová, S. (2005) · Revista de Neurología · doi:10.33588/rn.4106.2004353 · Cited by 13
[Sleep related eating disorders as a side effect of zolpidem].
Valiensi, S. M., Cristiano, E., Martínez, O. A., Reisin, R. C., & Alvarez, F. (2010) · PubMed · Cited by 13
Fort, P., Rampon, C., Gervasoni, D., Peyron, C., & Luppi, P. (1998) · PubMed · Cited by 13
Snoring, penile erection and loss of reflexive consciousness during REM sleep behavior disorder
Oudiette, D., Leclair‐Visonneau, L., & Arnulf, I. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.06.004 · Cited by 12
Nocturnal eating in restless legs syndrome
Nirenberg, M. J., & Waters, C. (2009) · Movement Disorders · doi:10.1002/mds.22797 · Cited by 11
Ju, Y. S., Larson‐Prior, L. J., & Duntley, S. P. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.05.001 · Cited by 9
Urticaria and Respiratory Distress Due to Porfimer Sodium
Karasic, D. S., & Pearson, V. E. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19352 · Cited by 7
Price, C. (1990) · BMJ · doi:10.1136/bmj.301.6756.875-a · Cited by 1
Louis (1999) · doi:10.1002/1531-8257(199905)14:3
Research works printed but not linked: 4
- Schenck, 2005, Zolpidem-induced Sleep-Related Eating Disorder (SRED) in 19 patients, Sleep, 28, a259
- Schenck, 1992, Does REM sleep behavior disorder protect against obstructive sleep apnea?, REM sleep behavior disorder protect against obstructive sleep apnea, 21, 21257
- Arkin, 1978, Night-Terrors as Anomalous REM sleep component manifestation in slow-wave sleep, Waking Sleeping, 2, 143
- Schenck, 2006, Topiramate therapy of sleep related eating disorder (SRED), Sleep, 29, a268
Cited by
Sorted by citations
Functions and Mechanisms of Sleep
Zielinski, M. R., McKenna, J. T., & McCarley, R. W. (2016) · AIMS neuroscience · doi:10.3934/neuroscience.2016.1.67 · Cited by 392
Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease
Howell, M. J., & Schenck, C. H. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4563 · Cited by 267
Self-citationHesse, S., Kreuzer, M., Hight, D., Gaskell, A. L., Devari, P., Singh, D., Taylor, N., Whalin, M. K., Lee, S., SLEIGH, J. W., et al. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.09.016 · Cited by 225
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence
McGrane, I. R., Leung, J. G., Louis, E. K. S., & Boeve, B. F. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.09.011 · Cited by 185
Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management
Maski, K. P., & Owens, J. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30204-6 · Cited by 144
Metadata
- Authors
- Howell, M. J.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Howell, Michael J.
- ORCID
- Howell, Michael J.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 9
- Issue
- 4
- Pages
- 753-775
- ISSN
- 1878-7479 (ISSN-L)
- PMC
- PMC3480572
- OpenAlex
- W2078251421
- Cited by
- 165
- References
- 258
- Citations by year
- 2026: 17 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 15 · 2019: 13 · 2018: 12 · 2017: 10 · 2016: 18 · 2015: 6 · 2014: 6 · 2013: 5 · 2012: 3
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neurotherapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Keywords
- parasomnias, sleepwalking, sleep-related eating disorder, REM sleep behavior disorder, restless legs syndrome, sleep inertia, cyclic alternating pattern, benzodiazepine receptor agonists, clonazepam, melatonin, paroxetine, central pattern generator, synucleinopathies, Parkinson's disease, sleep disorders comorbidity
- MeSH terms
- Humans, Parasomnias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
